The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference
HTML-код
- Опубликовано: 3 дек 2024
- Presenter: Michel Le May, MD
Director, University of Ottawa Heart Institute Regional STEMI Program,
University of Ottawa
Professor, Faculty of Medicine,
University of Ottawa